Fingolimod placebo, FINGOLIMOD, Ublituximab Placebo, ublituximab
TG1101-RMS-PED304
Phase 3 small_molecule active
Quick answer
Fingolimod placebo, FINGOLIMOD, Ublituximab Placebo, ublituximab for Relapsing Multiple Sclerosis is a Phase 3 program (small_molecule) at TG THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TG THERAPEUTICS, INC.
- Indication
- Relapsing Multiple Sclerosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active